NEW YORK (GenomeWeb News) – Cancer Genetics today said that its first-quarter revenues jumped 45 percent year over year, as it reported financial results for the first time as a publicly traded company.

Revenues for the three months ended March 31 were $1.2 million, compared to $834,752 during the first quarter in 2012. Clinical test volume increased to 1,911 tests in the quarter, up 19 percent from 1,610 in the year-ago period, while average revenue per test rose 23 percent to $615 from $502 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcripts, and more.

While James Watson and Francis Crick are credited for discovering the structure of DNA, Rich proved their theory of a double helix structure was correct when he produced a distinct image of the structure.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

According to MIT Technology Review, Apple is collaborating with researchers to develop apps for consumer DNA testing.